reported_detection_rates: rna-splicing-20261009-protocol-segarracasas2025-known-event-detection
Descriptive fact transcribed from the pinned source.
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
6 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| attributes.field reported_detection_rates Context-only references | Translating Muscle RNAseq Into the Clinic for the Diagnosis of Muscle Diseases Results 'Aberrant Splicing Detection' paragraph 3; Discussion paragraphs 5 and 10 Version: Annals of Clinical and Translational Neurology 12(7):1465, published online 2025-05-25; PMC12257123 full-text XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.source_locator Results 'Aberrant Splicing Detection' paragraph 3; Discussion paragraphs 5 and 10 Context-only references | Translating Muscle RNAseq Into the Clinic for the Diagnosis of Muscle Diseases Results 'Aberrant Splicing Detection' paragraph 3; Discussion paragraphs 5 and 10 Version: Annals of Clinical and Translational Neurology 12(7):1465, published online 2025-05-25; PMC12257123 full-text XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| attributes.value Results: FRASER |dPSI| > 0.1 identified 81.26% (13/16) of events, FRASER2 68.7% (11/16) and LeafCutterMD 25%. Discussion: FRASER2 detects 66.6% of pathogenic events. Context-only references | Translating Muscle RNAseq Into the Clinic for the Diagnosis of Muscle Diseases Results 'Aberrant Splicing Detection' paragraph 3; Discussion paragraphs 5 and 10 Version: Annals of Clinical and Translational Neurology 12(7):1465, published online 2025-05-25; PMC12257123 full-text XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| description Descriptive fact transcribed from the pinned source. Context-only references | Translating Muscle RNAseq Into the Clinic for the Diagnosis of Muscle Diseases Results 'Aberrant Splicing Detection' paragraph 3; Discussion paragraphs 5 and 10 Version: Annals of Clinical and Translational Neurology 12(7):1465, published online 2025-05-25; PMC12257123 full-text XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Relationship: subject rna-splicing-20261009-protocol-segarracasas2025-known-event-detection Context-only references | Translating Muscle RNAseq Into the Clinic for the Diagnosis of Muscle Diseases Results 'Aberrant Splicing Detection' paragraph 3; Discussion paragraphs 5 and 10 Version: Annals of Clinical and Translational Neurology 12(7):1465, published online 2025-05-25; PMC12257123 full-text XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| name reported_detection_rates: rna-splicing-20261009-protocol-segarracasas2025-known-event-detection Context-only references | Translating Muscle RNAseq Into the Clinic for the Diagnosis of Muscle Diseases Results 'Aberrant Splicing Detection' paragraph 3; Discussion paragraphs 5 and 10 Version: Annals of Clinical and Translational Neurology 12(7):1465, published online 2025-05-25; PMC12257123 full-text XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-10-10-5bcb3ccc9543 · Record review: source checked
1 source records and release history
- Translating Muscle RNAseq Into the Clinic for the Diagnosis of Muscle Diseases · Original source · Annals of Clinical and Translational Neurology 12(7):1465, published online 2025-05-25; PMC12257123 full-text XML
Technical metadata and extraction receipts
Stable ID: rna-splicing-20261009-claim-segarracasas2025-prose-detection-rates
- field
- reported_detection_rates
- value
- Results: FRASER |dPSI| > 0.1 identified 81.26% (13/16) of events, FRASER2 68.7% (11/16) and LeafCutterMD 25%. Discussion: FRASER2 detects 66.6% of pathogenic events.
- source locator
- Results 'Aberrant Splicing Detection' paragraph 3; Discussion paragraphs 5 and 10
- review
- method: source-hash-verification; ai-assisted-source-review; reviewer: claude; reviewer note: Separate Claude review agent, independent of the extractor; no human review claimed; date: 2026-10-09; artifact sha256: 6e61a917c80d08357fe7316ad84f5cb84ac457fcce4cb1d3b5bf866046e2095d; retrieval url: https://www.ebi.ac.uk/europepmc/webservices/rest/PMC12257123/fullTextXML; method note: Compared the claim with the cited paragraphs of the re-downloaded article XML.; note: Hand transcription from the article XML text. Pending independent review. Independent review 2026-10-09: wording matches the source; locator corrected to the paragraph that holds it.